Cardiol Therapeutics Inc (CRDL)
Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million
Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million
📈 **POSITIVE** • Low confidence analysis (56%) • Strong positive catalyst • High growth potential **Sentiment:** Positive (75%) **Content type:** General